Pegaspargase biosimilar (Xbrane)

培门冬酶生物类似药（Xbrane）

Report date: 2025/02/19 10:16:08

Base Information

Drug NamePegaspargase biosimilar (Xbrane)
Drug Alias NameXoncane
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Non-recombinant enzyme
Mechanisms of ActionAspartate-ammonia ligase inhibitorsAmidohydrolases stimulantsAsparagine inhibitors
TargetsAspartate-ammonia ligaseAmidohydrolasesAsparagine
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXbrane Biopharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXbrane Biopharma Ab
Active IndicationsN/A
Inactive IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A